Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV

A N Ananthakrishnan1, E L McGinley, J Fangman

  • 1Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. aanantha@mcw.edu

Journal of Viral Hepatitis
|December 17, 2009
PubMed

Insights

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection leads to more hospitalizations and increased mortality compared to HCV or HIV alone. This co-infection poses a significant risk for hospitalized patients.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Public Health

Background:

  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection is prevalent, affecting up to 10% of HCV patients and 25-30% of HIV patients.
  • Understanding the clinical outcomes of HCV/HIV co-infection is crucial for managing hospitalized patient populations.

Purpose of the Study:

  • To investigate the association between HCV/HIV co-infection and patient outcomes during hospitalization.
  • To compare liver-related and infection-related admissions between patients with HCV monoinfection, HIV monoinfection, and HCV/HIV co-infection.

Main Methods:

  • Utilized the 2006 Nationwide Inpatient Sample database.
  • Identified patient cohorts using ICD-9-CM codes for HCV monoinfection, HIV monoinfection, and HCV/HIV co-infection.
  • Employed multivariate logistic regression to determine predictors of in-hospital mortality.

Main Results:

  • HCV/HIV co-infected patients had higher rates of hospitalization (23.5%) compared to HCV (14.8%) or HIV (19.9%) monoinfection.
  • Liver-related admissions were more frequent in co-infected patients (15.4%) than in HIV monoinfection patients (3.3%).
  • HCV/HIV co-infection increased in-hospital mortality risk compared to HCV monoinfection (OR 1.41) and was a significant risk factor for mortality.

Conclusions:

  • HCV/HIV co-infection is linked to substantially higher hospitalization rates and serves as a risk factor for in-hospital mortality compared to isolated HCV.
  • HCV-associated cirrhosis significantly elevates mortality risk in patients with HIV.
  • Effective management strategies are needed for co-infected patients to mitigate adverse outcomes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...